Gubra A/S (CO:GUBRA) — Market Cap & Net Worth
Market Cap & Net Worth: Gubra A/S (GUBRA)
Gubra A/S (CO:GUBRA) has a market capitalization of $787.58 Million (Dkr5.03 Billion) as of September 23, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #10117 globally and #51 in its home market, demonstrating a -1.72% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Gubra A/S's stock price Dkr308.20 by its total outstanding shares 16333032 (16.33 Million). Also see Gubra A/S asset portfolio for a full breakdown of the balance sheet.
Gubra A/S Market Cap History: 2023 to 2026
Gubra A/S's market capitalization history from 2023 to 2026. Data shows growth from $319.43 Million to $787.58 Million (34.59% CAGR). Also see GUBRA cash flow conversion for how efficiently the company converts equity into cash flow.
Gubra A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Gubra A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Gubra A/S (GUBRA) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.50x
Gubra A/S's market cap is 0.50 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.78x
Gubra A/S's market cap is 0.78 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $319.43 Million | $205.00 Million | -$44.52 Million | 1.56x | N/A |
| 2024 | $1.59 Billion | $265.74 Million | -$36.50 Million | 6.00x | N/A |
| 2025 | $1.32 Billion | $2.64 Billion | $1.69 Billion | 0.50x | 0.78x |
Competitor Companies of GUBRA by Market Capitalization
Companies near Gubra A/S in the global market cap rankings as of September 23, 2026. Review tangible net worth ratio of Gubra A/S to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Gubra A/S by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #189 globally with a market cap of $129.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #336 globally with a market cap of $80.46 Billion USD.
- CSL Ltd (AU:CSL): Ranked #455 globally with a market cap of $61.21 Billion USD ( AU$86.50 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #508 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #189 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $129.45 Billion | $510.72 |
| #336 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $80.46 Billion | $798.17 |
| #455 | CSL Ltd | AU:CSL | $61.21 Billion | AU$178.30 |
| #508 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $172.94 |
Gubra A/S Historical Marketcap From 2023 to 2026
Between 2023 and today, Gubra A/S's market cap moved from $319.43 Million to $ 787.58 Million, with a yearly change of 34.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr787.58 Million | -40.44% |
| 2025 | Dkr1.32 Billion | -17.07% |
| 2024 | Dkr1.59 Billion | +399.20% |
| 2023 | Dkr319.43 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 22nd, 2026 the market cap of Gubra A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $787.58 Million USD |
| MoneyControl | $787.58 Million USD |
| MarketWatch | $787.58 Million USD |
| marketcap.company | $787.58 Million USD |
| Reuters | $787.58 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Gubra A/S
Gubra A/S, a disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally. It operates through three segments: Preclinical Contract Research (CRO), Biotech, and Gubra Green. The company offers preclinical contract research and development services within metabolic and fibrotic diseases for th… Read more